Line 93: | Line 93: | ||
<div class="captionPicture"> | <div class="captionPicture"> | ||
<img height=400 src="https://static.igem.org/mediawiki/2017/3/36/T--Munich--Improve_Plasmid_Map.svg"> | <img height=400 src="https://static.igem.org/mediawiki/2017/3/36/T--Munich--Improve_Plasmid_Map.svg"> | ||
− | <p><b>Figure 1 </b>The TEV plasmid map shows the binding sites of the overhang primers. Indicated are also coding sequence, terminator, T7 promotor and RBS</p> | + | <p><b>Figure 1:</b>The TEV plasmid map shows the binding sites of the overhang primers. Indicated are also coding sequence, terminator, T7 promotor and RBS</p> |
</div> | </div> | ||
</td> | </td> | ||
Line 105: | Line 105: | ||
<div class="captionPicture"> | <div class="captionPicture"> | ||
<img height=300 src="https://static.igem.org/mediawiki/2017/f/f1/T--Munich--Improve_TEV_SEC_SDS.png"> | <img height=300 src="https://static.igem.org/mediawiki/2017/f/f1/T--Munich--Improve_TEV_SEC_SDS.png"> | ||
− | <p><b>Figure 2</b> The TEV plasmid map shows the binding sites of the overhang primers. Indicated are also coding sequence, terminator, T7 promotor and RBS</p> | + | <p><b>Figure 2:</b> The TEV plasmid map shows the binding sites of the overhang primers. Indicated are also coding sequence, terminator, T7 promotor and RBS</p> |
</div> | </div> | ||
</td> | </td> | ||
Line 112: | Line 112: | ||
<div class="captionPicture"> | <div class="captionPicture"> | ||
<a href="#OH_PCR_Experiment_Popup"><img width=300 src="https://static.igem.org/mediawiki/2017/1/1b/T--Munich--Improve_TEV_OH_PCR.png"></a> | <a href="#OH_PCR_Experiment_Popup"><img width=300 src="https://static.igem.org/mediawiki/2017/1/1b/T--Munich--Improve_TEV_OH_PCR.png"></a> | ||
− | <p><b>Figure 3</b> PCR overhang for TEV His-tag</p> | + | <p><b>Figure 3:</b> PCR overhang for TEV His-tag</p> |
</div> | </div> | ||
Line 121: | Line 121: | ||
<div class="captionPicture"> | <div class="captionPicture"> | ||
<img height=600 src="https://static.igem.org/mediawiki/2017/c/c1/T--Munich--Improve_TEV_SEC.svg"> | <img height=600 src="https://static.igem.org/mediawiki/2017/c/c1/T--Munich--Improve_TEV_SEC.svg"> | ||
− | <p><b>Figure 4</b> The TEV plasmid map shows the binding sites of the overhang primers. Indicated are also coding sequence, terminator, T7 promotor and RBS</p> | + | <p><b>Figure 4:</b> The TEV plasmid map shows the binding sites of the overhang primers. Indicated are also coding sequence, terminator, T7 promotor and RBS</p> |
</div> | </div> | ||
</td> | </td> | ||
Line 138: | Line 138: | ||
<div class="captionPicture"> | <div class="captionPicture"> | ||
<img width=600 src="https://static.igem.org/mediawiki/2017/6/6b/T--Munich--Improve_TEV_Cleavage_final.png"> | <img width=600 src="https://static.igem.org/mediawiki/2017/6/6b/T--Munich--Improve_TEV_Cleavage_final.png"> | ||
− | <p><b> Figure 5</b> The SDS-PAGE showing the cleavage of our substrate after respective incubation time | + | <p><b> Figure 5:</b> The SDS-PAGE showing the cleavage of our substrate after respective incubation time</p> |
− | + | ||
</div> | </div> | ||
+ | <p>Next, the activity should be analyzed between 0 and 1 h to correctly evaluate the results. However, we highly purified our His-TEV protease and also used it successfully to process our Cas13a proteins. Here, we provide a BioBrick, which could be useful for all future iGEM teams.</p> | ||
</tr> | </tr> | ||
Revision as of 01:20, 2 November 2017
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|